Natco Pharma Increases Adcock Ingram Stake to 49%

Natco Pharma Limited has successfully completed the acquisition of an additional 13.25% equity stake in Adcock Ingram Holdings Proprietary Limited, increasing its total shareholding to 49%. The transaction, valued at approximately ZAR 1.81 billion (₹ 1,060 crores), was executed through Natco Pharma South Africa Proprietary Limited. This strategic move is a significant step in Natco Pharma's African growth strategy, building upon its initial 35.75% stake acquired in 2025. Adcock Ingram is a prominent South African pharmaceutical and healthcare company with a strong market presence.